Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Athersys Inc (ATHX)

Athersys Inc (ATHX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 368,796
  • Shares Outstanding, K 226,255
  • Annual Sales, $ 1,440 K
  • Annual Income, $ -78,760 K
  • 60-Month Beta -1.69
  • Price/Sales 248.25
  • Price/Cash Flow N/A
  • Price/Book 9.02
Trade ATHX with:

Options Overview

Details
  • Implied Volatility 147.25%
  • Historical Volatility 36.80%
  • IV Percentile 63%
  • IV Rank 36.14%
  • IV High 282.21% on 06/23/21
  • IV Low 70.88% on 07/23/21
  • Put/Call Vol Ratio 0.43
  • Today's Volume 76
  • Volume Avg (30-Day) 713
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 43,383
  • Open Int (30-Day) 48,771

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.11
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3500 +14.81%
on 07/19/21
1.6500 -6.06%
on 08/02/21
+0.0800 (+5.44%)
since 07/02/21
3-Month
1.3500 +14.81%
on 07/19/21
1.7700 -12.43%
on 06/08/21
-0.1200 (-7.19%)
since 04/30/21
52-Week
1.3500 +14.81%
on 07/19/21
3.0300 -48.84%
on 02/04/21
-1.0100 (-39.45%)
since 07/31/20

Most Recent Stories

More News
Athersys to Host Second Quarter Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2021 financial results at approximately 4:00 PM Eastern Time on Monday, August 9, 2021, and will host a conference call shortly thereafter...

ATHX : 1.5500 (-4.91%)
Soft Tissue Repair Global Market Report 2021: COVID-19 Growth And Change

Reportlinker.com announces the release of the report "Soft Tissue Repair Global Market Report 2021: COVID-19 Growth And Change" - https://www.reportlinker.com/p06103738/?utm_source=GNW

ATHX : 1.5500 (-4.91%)
CRY : 26.95 (-0.19%)
MDT : 131.26 (-0.04%)
SNN : 39.65 (-3.13%)
SYK : 270.07 (-0.32%)
ZBH : 163.01 (-0.25%)
New Publication Provides Further Clarity of MultiStem's Mechanism of Action on Modulating the Inflammatory Response in Critical Care Indications

Athersys, Inc. (NASDAQ: ATHX) announced today that data accumulated from several years of preclinical research was published in the peer-reviewed journal Scientific Reports. The publication describes the...

ATHX : 1.5500 (-4.91%)
Athersys to Present at the Bank of America Virtual Healthcare Conference on May 12

Ivor Macleod, Chief Financial Officer of Athersys Inc. (NASDAQ: ATHX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Wednesday, May 12, 2021 at 12:30 pm...

ATHX : 1.5500 (-4.91%)
Athersys, Inc. (ATHX) Upgraded to Buy: Here's What You Should Know

Athersys, Inc. (ATHX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ATHX : 1.5500 (-4.91%)
Athersys to Host First Quarter Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its first quarter 2021 financial results at approximately 4:00 PM Eastern Time on Thursday, May 6, 2021, and will host a conference call shortly thereafter at...

ATHX : 1.5500 (-4.91%)
Athersys to Present at the Needham Virtual Healthcare Conference on April 14

Athersys, Inc. (NASDAQ: ATHX) announced today that Mr. Ivor Macleod, Chief Financial Officer, will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference. The presentation...

ATHX : 1.5500 (-4.91%)
Athersys Reports That Healios Has Completed Enrollment in the ONE-BRIDGE Study of MultiStem(R) for Acute Respiratory Distress Syndrome in Japan

Athersys, Inc. (Nasdaq: ATHX) announced today that its partner HEALIOS K.K. (Healios) has completed enrollment in the ONE-BRIDGE study in Japan evaluating MultiStem(R) (invimestrocel) in patients with...

ATHX : 1.5500 (-4.91%)
Athersys Announces Financial Results for Fourth Quarter and Full Year 2020

Athersys, Inc. (NASDAQ: ATHX) announced today its fourth quarter 2020 and annual 2020 financial results and recent highlights.

ATHX : 1.5500 (-4.91%)
Thinking about buying stock in Lipocine, Athersys, Norwegian Cruise Line, Newage Inc, or GameStop?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPCN, ATHX, NCLH, NBEV, and GME.

ATHX : 1.5500 (-4.91%)
LPCN : 1.3700 (+3.79%)
NBEV : 1.9900 (+4.19%)
GME : 157.65 (-2.15%)
NCLH : 23.58 (-1.87%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Athersys, Inc., a late stage biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused primarily on treating critical care indications neurological conditions, cardiovascular diseases, inflammatory and...

See More

Key Turning Points

3rd Resistance Point 1.7267
2nd Resistance Point 1.6833
1st Resistance Point 1.6567
Last Price 1.5500
1st Support Level 1.5867
2nd Support Level 1.5433
3rd Support Level 1.5167

See More

52-Week High 3.0300
Fibonacci 61.8% 2.3882
Fibonacci 50% 2.1900
Fibonacci 38.2% 1.9918
Last Price 1.5500
52-Week Low 1.3500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar